Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.397NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.277NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.294NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used